Product Code: ETC200136 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 | |
India nuclear medicine radioisotopes market is expected to grow at a CAGR of 8.6%. The growth can be attributed to the increasing prevalence of cancer, rising geriatric population, and growing availability of PET (positron emission tomography) imaging centers in India. Moreover, the development of advanced radiopharmaceuticals has further boosted the demand for radioisotopes in India. Additionally, rising awareness regarding early diagnosis and treatment of diseases are projected to drive the market during the forecast period. Furthermore, favorable government initiatives such as Make In India scheme are likely to propel the industry growth over the projected timeframe.
Cancer is one among many major causes contributing towards death worldwide along with heart diseases and several others affecting human beings globally on a large scale basis; this factor has surged up considerable demand for precise medical diagnostics which helps or aids doctors in determining an accurate problem faced by patient respectively due to which nuclear medicine radioisotopes have gained huge traction within healthcare sector especially diagnostics and imaging departments making it easier for doctors/physicians/surgeons through its radioactive tracers helping them identify abnormal cells easily leading towards more successful treatments while observing reactions inside body parts affected with aforementioned disease thereby propelling overall market size significantly Growing number of PET imaging centers in India: Positron Emission Tomography (PET) plays prominent role within medical industry since it helps physicians diagnose several diseases like Alzheimer???s better using highly sophisticated methods including reading signals related with brain activity remarkably well also indicating presence malignant tumors accurately via detailed scans henceforth prompting most healthcare organizations across country open separate Imaging Centers dedicated specifically for PET Scanning leading towards higher consumption rate concerning radionuclides especially Tc-99m generated through Cyclotrons being used heavily as tracers as per requirement while widening scope pertaining Nuclear Medicine Radioisotope Market considerably.
High cost associated with radioactive isotope production & maintenance: Production process involving generation & purification required for manufacturing different types radiation emitting Isotopes is quite expensive primarily owing usage multiple components ranging from hardware devices inclusive cyclotrons being utilized generate desired element alongside special chemicals aiding purification procedure due which manufacturing cost incurred turns out be unaffordable certain sections society resulting lower adoption rates respective products factors restraining overall India Nuclear Medicine Radioisotope Industry extensively.
Covid-19 has had a significant impact on this industry as well due to disruption in supply chains leading to decrease in production rate; however, it is expected that post-pandemic there will be an upsurge in demand for medical isotopes as other treatments like chemotherapy become less preferred due to their effects on immunity system among other reasons.
Key players operating India Nuclear Medicine Radioisotope Market are, GE Healthcare India Private Limited, Jubilant Life Sciences Ltd.,Siemens Healthineers India Pvt Ltd, and Mallinckrodt plc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Nuclear Medicine Radioisotopes Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Nuclear Medicine Radioisotopes Market Revenues & Volume, 2021 & 2031F |
3.3 India Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
3.4 India Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
3.5 India Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By By Types, 2021 & 2031F |
3.6 India Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By By Application, 2021 & 2031F |
4 India Nuclear Medicine Radioisotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Nuclear Medicine Radioisotopes Market Trends |
6 India Nuclear Medicine Radioisotopes Market, By Types |
6.1 India Nuclear Medicine Radioisotopes Market, By By Types |
6.1.1 Overview and Analysis |
6.1.2 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By By Types, 2021-2031F |
6.1.3 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2021-2031F |
6.1.4 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2021-2031F |
6.1.5 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2021-2031F |
6.1.6 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2021-2031F |
6.1.7 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2021-2031F |
6.1.8 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2021-2031F |
6.1.9 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
6.2 India Nuclear Medicine Radioisotopes Market, By By Application |
6.2.1 Overview and Analysis |
6.2.2 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2021-2031F |
6.2.3 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2021-2031F |
6.2.4 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2021-2031F |
6.2.5 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2021-2031F |
6.2.6 India Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021-2031F |
7 India Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
7.1 India Nuclear Medicine Radioisotopes Market Export to Major Countries |
7.2 India Nuclear Medicine Radioisotopes Market Imports from Major Countries |
8 India Nuclear Medicine Radioisotopes Market Key Performance Indicators |
9 India Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
9.1 India Nuclear Medicine Radioisotopes Market Opportunity Assessment, By By Types, 2021 & 2031F |
9.2 India Nuclear Medicine Radioisotopes Market Opportunity Assessment, By By Application, 2021 & 2031F |
10 India Nuclear Medicine Radioisotopes Market - Competitive Landscape |
10.1 India Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2024 |
10.2 India Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |